Molecule Details
| InChIKey | XFARUGBBAMTOCU-IBSXUBTNSA-M |
|---|---|
| Compound Name | (5R,6Z)-6-(6,7-dihydro-5H-cyclopenta-[d]imidazo[2,1-b][1,3]thiazol-2-ylmethylene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium |
| Canonical SMILES | O=C([O-])C1=CS[C@@H]2/C(=C\c3cn4c5c(sc4n3)CCC5)C(=O)N12 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Unknown |
| Avg pChEMBL | 7.87 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P62593 | bla | Escherichia coli | Pathogen | PF13354 | 9.0 | IC50 | ChEMBL;BindingDB |
| P00811 | ampC | Escherichia coli (strain K12) | Pathogen | PF00144 | 8.7 | IC50 | ChEMBL;BindingDB |
| Q46991 | imiA | Enterobacter cloacae | Pathogen | PF13354 | 7.1 | IC50 | ChEMBL |
| P25910 | ccrA | Bacteroides fragilis | Pathogen | — | 6.6 | IC50 | ChEMBL;BindingDB |